# Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

> **NCT03246113** · PHASE1 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 1 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Cannabis
- **DRUG:** Temozolomide
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT03246113
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-19
- **Primary completion:** 2019-05-09
- **Final completion:** 2019-05-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of subject interest due to study design
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246113, "Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03246113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*